Lyell Immunopharma has acquired worldwide rights from ICT to LYL273, an advanced CAR T-cell candidate for metastatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback